Concerning AD, there is evidence that an immoderate amount of ROS can increase Aβ fibril production and aggregation, tau phosphorylation, and neuronal cell death, as well as trigger a whole series of events leading to neurodegeneration (such as mitochondrial dysfunction and glial cell activation) [16,17]. This evidence concerns the gene MAPT and Alzheimer disease.